Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Novel ADAMTS13 Mutation in a Patient With Congenital TTP Diagnosed in Pregnancy

Mawalla WF. et al, (2025), American Journal of Hematology

RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).

Wong MK. et al, (2025), J Clin Oncol

Precision Prevention Studies: A Targeted Approach to Cancer Prevention.

Blagden SP. et al, (2025), Cancer Prev Res (Phila), OF1 - OF9

Ex vivo model of functioning human lymph node reveals role for innate lymphocytes and stroma in response to vaccine adjuvant.

Fergusson JR. et al, (2025), Cell Rep, 44

First in vitro and in vivo experiments with ultra high-dose rate oxygen ion radiotherapy

Karle C. et al, (2025), Physics and Imaging in Radiation Oncology, 100803 - 100803

Spatial metabolomics informs the use of clinical imaging for improved detection of cribriform prostate cancer.

Sushentsev N. et al, (2025), Proc Natl Acad Sci U S A, 122

Silencing of SOD1 sensitises ATRX-deficient cells to camptothecin treatment through increased activity of the Alternative Lengthening of Telomeres pathway

ROSE A. et al, (2025), Human Molecular Genetics

Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer.

Zeisig B. et al, (2025), Blood

Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.

Ward JC. et al, (2025), J Pathol

Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A.

Brierley CK. et al, (2025), Nat Genet

Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer.

Nag S. et al, (2025), ESMO Open, 10

A novel synergistic drug combination of a mitogen-activated extracellular signal-regulated kinase inhibitor with [177Lu]Lu-rhPSMA-10.1 for prostate cancer treatment: Results of a preclinical evaluation.

Foxton C. et al, (2025), Nucl Med Biol, 146-147

Impact of Long-Term Chemotherapy on Outcomes in Pancreatic Ductal Adenocarcinoma: A Real-World UK Multi-Centre Study.

Mahmood U. et al, (2025), Cancers (Basel), 17

Epithelial GREMLIN1 disrupts intestinal epithelial-mesenchymal crosstalk to induce a wnt-dependent ectopic stem cell niche through stromal remodelling.

Mulholland EJ. et al, (2025), Nat Commun, 16

Preferences for multi-cancer tests (MCTs) in primary care: discrete choice experiments of general practitioners and the general public in England

Buckell J. et al, (2025), British Journal of Cancer

SRSF2 overexpression induces transcription-/replication-dependent DNA double-strand breaks and interferes with DNA repair pathways to promote lung tumor progression.

Khalife M. et al, (2025), NAR Cancer, 7

A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance—A Role for Nicotinamide N-Methyltransferase

Wright JA. et al, (2025), Cells, 14, 819 - 819

Screening for prostate cancer.

Kotecha P. et al, (2025), BMJ, 389

Iatrogenic Subcapsular Haematoma Leads to 151% Growth of Future Liver Remnant.

Fu H. et al, (2025), Cardiovasc Intervent Radiol

Investigating the therapeutic potential of FLASH radiotherapy - a treatment planning study.

Hörberger F. et al, (2025), Radiother Oncol, 209

Load More

1
2
3
4
5
6
7
...
»